Ipamorelin in human research: GH response and postoperative ileus

This Research Library page summarizes independently published research on Ipamorelin. For each study, the research model, key finding, and main limitation are provided.

Study 1

Evidence level: Human research - dose escalation

Subject: Relationship between dose, blood concentration, and GH release.

Key finding: A dose-dependent GH response was modeled.

Main limitation: Pharmacological study; no clinical benefits or long-term safety established.

Source: Original publication via PubMed

Study 2

Evidence level: Human research - phase 2 RCT

Subject: Ipamorelin after intestinal resection.

Key finding: The median time to a tolerated meal did not differ statistically significantly from placebo.

Main limitation: No convincing efficacy signal for the primary clinical objective studied.

Source: Original publication via PubMed

Scientific distinction: Research on a molecule, research model, or pharmaceutical formulation does not constitute evidence of the efficacy, safety, purity, or suitability of a commercial Peptidera product. This page does not provide treatment or usage advice.

Header image: illustrative visualization, not a research result.